MS
Morgan Stanley
MS has the edge over SRBK overall, supported by stronger fundamentals and stronger valuation.
SRBK
SR Bancorp, Inc. Common stock
SRBK has lower modeled downside risk, despite its lower overall score.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
SRBK Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| N/A | |
| N/A |
SRBK's profitability is currently healthy. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like SRBK.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
SRBK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 24x | $18.83 | — |
| Cheap | 30x | $15.00 | -20% |
| Fair | 32x | $16.06 | -15% |
| Current | 38x | $18.83 | — |
| Expensive | 41x | $20.75 | +10% |
Historical ranges are pointers, not guarantees.
SRBK has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
SRBK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for SRBK, with profitability improving.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over SRBK in the latest year-over-year earnings comparison.
SRBK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.77 | +54% |
| Q3 2026 | $0.50 | -7.4% |
| Q2 2026 | $0.44 | -28% |
SRBK earned $0.50 per share over the past year, down 7.4% from the year before.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over SRBK in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over SRBK on profitability, with a higher operating margin.
SRBK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $8.9M | +9.1% |
| Q1 2026 | $8.4M | +8.2% |
| Q4 2025 | $8.4M | +6.4% |
| Q3 2025 | $8.2M | -2.8% |
| Q1 2025 | $7.7M | -12% |
| Q4 2024 | $7.9M | -16% |
| Q3 2024 | $8.4M | +80% |
SRBK's revenue is growing: $9M last quarter, up 9.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 16% | +5.1 points |
| Q2 2026 | 15% | N/A |
| Q1 2026 | 14% | +5.9 points |
| Q4 2025 | 13% | -4.1 points |
| Q3 2025 | 11% | -9.6 points |
| Q1 2025 | 8.1% | -7.3 points |
| Q4 2024 | 17% | -4.4 points |
| Q3 2024 | 21% | +288 points |
SRBK's operating margin was 16% last quarter, up 5.1 points from the same quarter a year ago.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
SRBK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.7M | +140% |
| Q2 2026 | $3.8M | +141% |
| Q1 2026 | $1.9M | -25% |
| Q4 2025 | $3.1M | +$4.6M |
| Q3 2025 | $1.1M | -33% |
| Q2 2025 | $1.6M | -60% |
| Q1 2025 | $2.5M | +345% |
| Q4 2024 | -$1.5M | -$557K |
SRBK has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has 1.6B diluted shares, down 1.5% from a year ago.
SRBK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -4.1% | -311K shares |
| 1 year | -7.6% | -602K shares |
SRBK has the edge over MS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $328,000 |
| Q2 2026 | $4M |
| Q1 2026 | $5M |
| Q4 2025 | $4.1M |
| Q3 2025 | $2.9M |
| Q2 2025 | $4M |
| Q1 2025 | $3.4M |
| Q4 2024 | $3.2M |
SRBK spent $13M buying back its own shares over the past year, about the same as the year before.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
SRBK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -7.9x | Net Cash |
| Q2 2026 | -10.0x | Net Cash |
| Q1 2026 | -7.6x | Net Cash |
| Q4 2025 | -4.4x | Net Cash |
| Q3 2025 | -3.1x | Net Cash |
| Q2 2025 | -3.3x | Net Cash |
| Q1 2025 | -9.2x | Net Cash |
| Q4 2024 | -5.4x | Net Cash |
SRBK has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
SRBK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.0 | Neutral |
| Stochastic | 36.0 | Neutral |
SRBK's weekly RSI is 51 (neutral) and its Stochastic is 36 (neutral).
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS has the edge over SRBK on valuation relative to its sector.
SRBK PE vs Financial Services Sector
| Metric | SRBK | Sector median | Relative |
|---|---|---|---|
| PE | 38x | 13x | 189% above |
| PE % | 79 | 43 | 36 pts above |
SRBK is trading at 38x earnings, a 189% premium to the Financial Services sector's median of 13x.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
SRBK has stronger trend alignment. MS is above 3 of 5 weekly averages versus SRBK above 3 of 4.
SRBK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.7 | 0.7% above |
| 20 week MA | $19.2 | 2% below |
| 50 week MA | $18.2 | 3.7% above |
| 100 week MA | $15.8 | 19% above |
SRBK's trend is mixed: it's above three of its four weekly moving averages, and 19% above its 100-week average.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.
SRBK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $9.15 | $9.56 | +4.5% |
| 2024 | $9.56 | $12.1 | +27% |
| 2025 | $12.1 | $16.2 | +34% |
| 2026 YTD | $16.2 | $18.8 | +16% |
SRBK has the edge over MS on returns for 2026, with the stronger performance.